Internal Medicine, Endocrinology, Diabetes, & Metabolism · Portland, OR
NPI
1265448864
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3181 SW Sam Jackson Park Rd
Portland, OR, 97239
Phone (503) 494-5732
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
472 services
Medicare patients, 2024
189
Average age 73
Drug cost, 2024
$2.3M
3,174 prescriptions
Company payments, 2025
$22K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul B Duell was code 99214 (office e&m - established), 204 times for 145 patients. In total Paul B Duell billed 472 services in 8 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 204 | 145 | $90.20 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 202 | 158 | $13.46 | $2,718 |
| 99205 Office E&M - New | Office | 29 | 29 | $173.76 | $5,039 |
| 99443 Telephone Services | Office | 16 | 13 | $93.32 | $1,493 |
| 99215 Office E&M - Established | Office | 12 | 11 | $122.53 | $1,470 |
By year: 2022 $22K for 273 services; 2023 $21K for 258 services; 2024 $30K for 472 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul B Duell prescribed most often to Medicare patients was Ezetimibe, with 652 prescriptions and refills. In total Paul B Duell wrote 3,174 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ezetimibe Generic | 652 | 1,923 | 201 | $17K |
| Rosuvastatin Calcium Generic | 323 | 949 | 101 | $4,658 |
| Atorvastatin Calcium Generic | 212 | 569 | 61 | $1,930 |
| Repatha Sureclick Evolocumab | 156 | 352 | 36 | $193K |
| Ozempic Semaglutide | 115 | 177 | 24 | $161K |
| Nexletol Bempedoic Acid | 100 | 252 | 34 | $89K |
| Metformin Hcl Generic | 90 | 267 | 29 | $1,328 |
| Amlodipine Besylate Generic | 84 | 204 | 16 | $904 |
| Praluent Pen Alirocumab | 79 | 157 | 19 | $79K |
| Lisinopril Generic | 79 | 213 | 20 | $696 |
| Jardiance Empagliflozin | 73 | 185 | 19 | $101K |
| Levothyroxine Sodium Generic | 67 | 197 | 18 | $987 |
| Mounjaro Tirzepatide | 65 | 65 | Under 11 | $66K |
| Trulicity Dulaglutide | 54 | 64 | Under 11 | $62K |
| Losartan Potassium Generic | 42 | 127 | 16 | $700 |
Brand drugs: - claims; generic drugs: 2,208 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul B Duell $22K ($22K in general payments such as food, travel and fees) from 9 companies. The largest payer was Ionis Pharmaceuticals, Inc. with $14K.
| Company | Payments | Amount |
|---|---|---|
| Ionis Pharmaceuticals, Inc. IONS | 14 | $14K |
| Regeneron Pharmaceuticals, Inc. REGN | 2 | $2,860 |
| Chiesi USA, Inc. | 1 | $2,000 |
| Novo Nordisk Inc NVO | 4 | $1,890 |
| Amgen Inc. AMGN | 2 | $252 |
| Merck Sharp & Dohme LLC MRK | 1 | $90.8 |
| Esperion Therapeutics, Inc. ESPR | 1 | $85.2 |
| Madrigal Pharmaceuticals MDGL | 1 | $83.02 |
| Mirum Pharmaceuticals, Inc. MIRM | 1 | $78.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.